Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels |
---|---|---|---|---|
1 | ||||
Hypersensitivity | Hypersensitivity | postmarketing | x | |
Hypotension | Hypotension | postmarketing | x | |
Shock | Shock | postmarketing | x | |
Sepsis | Sepsis | postmarketing | x | |
Anaemia | Anaemia | x | ||
Coagulopathy | Clotting | x | ||
Coagulopathy | x | |||
Pancreatitis | Pancreatitis | x | ||
Pruritus | Pruritus | x | ||
Prothrombin level increased | Prothrombin level increased | x | ||
Wound haemorrhage | Wound haemorrhage | x | ||
Anaphylactic shock | Anaphylactoid reaction | x | ||
Anaphylactoid reaction | Anaphylactoid reaction | x | ||
Amylase increased | Serum amylase increased | x | ||
Haematocrit decreased | Haematocrit decreased | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||
---|---|---|---|---|
Hypovolaemia | x | |||
Sepsis | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |